HelpClose
If you encounter any technical issues as you edit, please report them.
3 noticesClose

Warning: You are not logged in! We appreciate you want to improve our articles. It is possible to save your changes anonymously to WikiLectures, however, your IP address will be recorded in this page's edit history. But if you want to log in or create a new account to save your contribution under your user name, you can do so.

You do not have permission to edit this page, for the following reason:

You must confirm your email address before editing pages. Please set and validate your email address through your user preferences.

You are using a browser which is not officially supported by this editor.

Crigler-Najjar syndrome

From WikiLectures

Template:Infobox - Genetic disease


Crigler-Najjar syndrome type I[edit | edit source]

  • AR hereditary complete defect of bilirubin-uridine diphosphate-glucuronyl-transferase (UDPG-transferase, UGT1A1) hepatocytes.
  • The most severe indirect (unconjugated) hyperbilirubinemia with early complications (nuclear jaundice).

Etiology[edit | edit source]

  • Complete absence of bilirubin-uridine diphosphate glucuronyl transferase → bilirubin conjugation disorder → bilirubin cannot be excreted in the bile

Clinical course[edit | edit source]

  • Icterus with a sharp rise in unconjugated bilirubin during the first hours of life.
  • Bile is colorless.
  • Stool is brown - the transfer of unconjugated bilirubin through the intestinal mucosa.
  • Urine is light, no bilirubin can be detected in it (unconjugated does not pass into the urine)
  • Without therapy, nuclear icterus soon develops.

Diagnosis[edit | edit source]

  • Lack of UDPG-trasferase activity in the liver

Therapy[edit | edit source]

  • Intensive phototherapy and exchange blood transfusion, cholestyramine administration.
  • Liver transplantation[1].

Crigler-Najjar syndrom type II[edit | edit source]

  • AD hereditary partial defect in bilirubin uridine diphosphate glucuronyl transferase (UDPG transferase) hepatocytes.
  • Mild indirect (unconjugated) hyperbilirubinemia.

Clinical course[edit | edit source]

  • Icterus with unconjucated hyperbilirubinemia.
  • Bile and urine are stained, conjugated bilirubin can be detected.

Diagnosis[edit | edit source]

  • Lower activity of UDPG-transferase in the liver.

Therapy[edit | edit source]

  • Enzyme induction by phenobarbital[1].


Links[edit | edit source]

Related articles[edit | edit source]

References[edit | edit source]

  1. Jump up to: a b MUNTAU, Ania Carolina. Pediatrisc. 4. edition. Praha : Grada, 2009. pp. 386-388. ISBN 978-80-247-2525-3.


Source[edit | edit source]

Template:Infobox - Genetic disease

Crigler-Najjar syndrome type I

  • AR hereditary complete defect of bilirubin-uridine diphosphate-glucuronyl-transferase (UDPG-transferase, UGT1A1) hepatocytes.

  • The most severe indirect (unconjugated) hyperbilirubinemia with early complications (nuclear jaundice).

Etiology

  • Complete absence of bilirubin-uridine diphosphate glucuronyl transferase → bilirubin conjugation disorder → bilirubin cannot be excreted in the bile

Clinical course

  • Icterus with a sharp rise in unconjugated bilirubin during the first hours of life.

  • Bile is colorless.

  • Stool is brown - the transfer of unconjugated bilirubin through the intestinal mucosa.

  • Urine is light, no bilirubin can be detected in it (unconjugated does not pass into the urine)

  • Without therapy, nuclear icterus soon develops.

Diagnosis

  • Lack of UDPG-trasferase activity in the liver

Therapy

  • Intensive phototherapy and exchange blood transfusion, cholestyramine administration.

  • Liver transplantation[1].

Crigler-Najjar syndrom type II

  • AD hereditary partial defect in bilirubin uridine diphosphate glucuronyl transferase (UDPG transferase) hepatocytes.

  • Mild indirect (unconjugated) hyperbilirubinemia.

Clinical course

  • Icterus with unconjucated hyperbilirubinemia.

  • Bile and urine are stained, conjugated bilirubin can be detected.

Diagnosis

  • Lower activity of UDPG-transferase in the liver.

Therapy

  • Enzyme induction by phenobarbital[1].

References

  1. 1 2 MUNTAU, Ania Carolina. Pediatrisc. 4. edition. Praha : Grada, 2009. pp. 386-388. ISBN 978-80-247-2525-3.

Source